WXXWY Financials: WuXi Biologics (Cayman) Inc AI Analysis

Home

Stock

WXXWY

Financials

WXXWY Financial

WuXi Biologics (Cayman) Inc

$8.91

6.07%

$0.5

At close: Mar 24, 16:00:00 GMT-4

$8.91

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$8.4

Open

$8.69

Day's Range

$8.69 - $8.96

52 week range

$4.14 - $11.21

Volume

40.1K

Avg.Volume

50.1K

Dividend yield

EPS (TTM)

0.28

Market Cap

$36.8B

What is WXXWY?

Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. The company is headquartered in Wuxi, Jiangsu and currently employs 12,552 full-time employees. The company went IPO on 2017-06-13. The firm mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The firm mainly conducts its business in the domestic and overseas markets.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

WXXWY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	20,054	18,675	17,034	15,268	10,290	5,612
Revenue Growth (YoY)	17%	10%	12%	48%	83%	41%
Cost of Revenue	11,500	11,024	10,206	8,544	5,461	3,079
Gross Profit	8,553	7,650	6,827	6,724	4,828	2,532
Selling, General & Admin	2,297	2,298	2,109	1,691	1,157	726
Research & Development	765	766	785	682	501	303
Operating Expenses	2,983	2,821	2,680	2,166	1,520	888
Other Non Operating Income (Expenses)	-5	-10	-10	-10	-9	--
Pretax Income	6,154	4,834	4,173	5,357	3,993	1,965
Income Tax Expense	1,232	889	603	807	484	273
Net Income	4,196	3,356	3,399	4,420	3,388	1,688
Net Income Growth	59%	-1%	-23%	30%	101%	67%
Shares Outstanding (Diluted)	4,185.75	4,227.16	4,348.87	4,375.9	4,421.79	4,209.16
Shares Change (YoY)	-2%	-3%	-1%	-1%	5%	5%
EPS (Diluted)	0.98	0.78	0.78	1.01	0.76	0.4
EPS Growth	62%	0%	-23%	32%	91%	57.99%
Free Cash Flow	1,759	1,287	447	-326	-3,091	-4,143
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	42.64%	40.96%	40.07%	44.03%	46.91%	45.11%
Operating Margin	27.77%	25.85%	24.34%	29.84%	32.14%	29.29%
Profit Margin	20.92%	17.97%	19.95%	28.94%	32.92%	30.07%
Free Cash Flow Margin	8.77%	6.89%	2.62%	-2.13%	-30.03%	-73.82%
EBITDA	--	6,266	5,316	5,357	3,789	1,947
EBITDA Margin	--	33.55%	31.2%	35.08%	36.82%	34.69%
D&A For EBITDA	--	1,437	1,169	800	481	303
EBIT	5,570	4,829	4,147	4,557	3,308	1,644
EBIT Margin	27.77%	25.85%	24.34%	29.84%	32.14%	29.29%
Effective Tax Rate	20.01%	18.39%	14.45%	15.06%	12.12%	13.89%

Follow-Up Questions

What are WuXi Biologics (Cayman) Inc's key financial statements?



According to the latest financial statement (Form-10K), WuXi Biologics (Cayman) Inc has a total asset of $56,977, Net profit of $3,356

What are the key financial ratios for WXXWY?



WuXi Biologics (Cayman) Inc's Current ratio is 3.75, has a Net margin is 17.97, sales per share of $4.41.

How is WuXi Biologics (Cayman) Inc's revenue broken down by segment or geography?



WuXi Biologics (Cayman) Inc largest revenue segment is Biologics, at a revenue of 15,972,158,570 in the most earnings release.For geography, North America is the primary market for WuXi Biologics (Cayman) Inc, at a revenue of 11,596,649,464.

Is WuXi Biologics (Cayman) Inc profitable?



yes, according to the latest financial statements, WuXi Biologics (Cayman) Inc has a net profit of $3,356

Does WuXi Biologics (Cayman) Inc have any liabilities?



yes, WuXi Biologics (Cayman) Inc has liability of 15,158

How many outstanding shares for WuXi Biologics (Cayman) Inc?



WuXi Biologics (Cayman) Inc has a total outstanding shares of 4,105.93

WuXi Biologics (Cayman) Inc (WXXWY) Financial

WXXWY Stock Price Chart